RxDoctor Payments Data

Flora Wu

Family · Brooklyn, NYNPI 1720001282

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,153 of the $1,650 with a category attached, or 69.9%. It is spread thinly across 21 manufacturers, the largest accounting for just 17.1%. Reporting peaked in 2021 at $1,439 and has fallen 98.7% since, to $19 in 2023.

$1,650in general payments, 2019–2025

Across 75 payments — averaging $22.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Incyte Corporation$282
  • Amgen$225
  • Lilly USA, LLC$191
  • E.r. Squibb & Sons, L.L.C.$176
  • Seagen Inc.$126
  • Takeda Pharmaceuticals U.S.A., Inc.$100
  • plus $551 from 15 others

What the payments were for

  • Food & beverage$1,15370%
  • Education$49730%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,650 in reported general payments places this provider in the 80th percentile of 8,883 family providers in New York.

See all family providers in New York →

Other family in Brooklyn

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →